NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in ClevelandGlobeNewsWire • 09/10/24
NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceGlobeNewsWire • 09/05/24
NeuroOne Medical Technologies Corporation (NMTC) Q3 2024 Earnings Call TranscriptSeeking Alpha • 08/14/24
NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/14/24
NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14GlobeNewsWire • 08/12/24
NeuroOne Medical Technologies Corporation (NMTC) Q2 2024 Earnings Call TranscriptSeeking Alpha • 05/15/24
NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/14/24
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14GlobeNewsWire • 05/10/24
NeuroOne Medical Technologies Corporation (NMTC) Q1 2024 Earnings Call TranscriptSeeking Alpha • 02/14/24
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateGlobeNewsWire • 02/13/24
NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13GlobeNewsWire • 02/08/24
NeuroOne Medical Technologies Corporation (NMTC) Q4 2023 Earnings Call TranscriptSeeking Alpha • 12/14/23
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate UpdateGlobeNewsWire • 12/14/23
NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14GlobeNewsWire • 12/07/23
NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural ProbeGlobeNewsWire • 11/16/23
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 11/14/23